Iran’s health system is under unprecedented strain as a combination of geopolitical friction and economic turbulence squeezes the flow of essential medicines. The escalation of the US-Israeli war against Tehran has reverberated far beyond the battlefield, reaching pharmacies where ordinary citizens search for life-saving drugs.
For many families, the crisis is not abstract statistics but daily dilemmas. One such household belongs to Ali Mohseni a 32-year-old living in Tehran, whose 74-year-old mother depends on a steady supply of insulin. Before the conflict intensified, a five-pack of insulin pens could be purchased at virtually any pharmacy, a routine that now feels like a relic of the past.
Insulin price surge and scarcity in Tehran
Since the war began, the cost of a five-pack of insulin pens has more than tripled. Mohseni explains that what once cost a modest sum now requires a significant portion of a family’s monthly budget. The scarcity is equally stark; he often has to traverse multiple drugstores before finding a single box, and even then the stock may be insufficient for his mother’s daily dosage.
“She cannot simply stop taking it” Mohseni, 32, said, underscoring the urgency of the situation. The insulin is an essential, life-sustaining medication and any interruption could lead to severe health complications for his mother, who has managed her condition for decades.
War, sanctions and shipping bottlenecks strain Iran’s pharmaceutical supply
The surge in price and the plummeting availability are not isolated incidents. The broader market has been hit by a cascade of disruptions: international sanctions limit Iran’s ability to import raw materials, while shipping restrictions make maritime routes unreliable. These constraints have crippled the country’s domestic drug manufacturers, forcing them to rely on dwindling foreign shipments.
Economic pressures on everyday Iranians
Compounding the logistical hurdles, Iran grapples with soaring inflation and a weakening rial. The devaluation of the national currency inflates the local price of imported medicines, turning previously affordable treatments into luxury items for many citizens. The economic squeeze has turned a medical necessity into a financial jeopardy for families like the Mohsenis.
Impact on vulnerable patients
For patients with chronic conditions, the consequences are stark. The lack of reliable insulin supply threatens to increase hospital admissions for diabetic emergencies, placing further stress on an already overstretched health infrastructure. As pharmacies empty their shelves, the risk of untreated diabetes rises, potentially reversing years of public-health gains.
While the government has pledged to address the shortage, the intertwined challenges of political isolationeconomic instability and disrupted supply chains mean that short-term relief remains elusive. Families continue to navigate a new reality where securing a handful of insulin pens can feel like a battle against an invisible enemy.
